Detalhe da pesquisa
1.
Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinoma.
Genes Dev
; 38(1-2): 46-69, 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38286657
2.
Emerging Roles for Polycomb-Group Proteins in Stem Cells and Cancer.
Trends Biochem Sci
; 44(8): 688-700, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31085088
3.
PDGFRA defines the mesenchymal stem cell Kaposi's sarcoma progenitors by enabling KSHV oncogenesis in an angiogenic environment.
PLoS Pathog
; 15(12): e1008221, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31881074
4.
Loss of function of GATA3 regulates FRA1 and c-FOS to activate EMT and promote mammary tumorigenesis and metastasis.
Cell Death Dis
; 14(6): 370, 2023 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37353480
5.
Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinoma.
bioRxiv
; 2023 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38076924
6.
Loss of function of GATA3 induces basal-like mammary tumors.
Theranostics
; 12(2): 720-733, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34976209
7.
Endocrine resistance and breast cancer plasticity are controlled by CoREST.
Nat Struct Mol Biol
; 29(11): 1122-1135, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36344844
8.
Epigenetic mechanisms in breast cancer therapy and resistance.
Nat Commun
; 12(1): 1786, 2021 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33741974
9.
Estrogen induces dynamic ERα and RING1B recruitment to control gene and enhancer activities in luminal breast cancer.
Sci Adv
; 6(23): eaaz7249, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32548262
10.
Immune Checkpoint Inhibitors: Basics and Challenges.
Curr Med Chem
; 26(17): 3009-3025, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-28782469
11.
Polycomb complexes associate with enhancers and promote oncogenic transcriptional programs in cancer through multiple mechanisms.
Nat Commun
; 9(1): 3377, 2018 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30139998
12.
p16 loss rescues functional decline of Brca1-deficient mammary stem cells.
Cell Cycle
; 16(8): 759-764, 2017 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28278054
13.
Gata3 restrains B cell proliferation and cooperates with p18INK4c to repress B cell lymphomagenesis.
Oncotarget
; 7(39): 64007-64020, 2016 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-27588406
14.
p16INK4a suppresses BRCA1-deficient mammary tumorigenesis.
Oncotarget
; 7(51): 84496-84507, 2016 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27811360
15.
p19Ink4d is a tumor suppressor and controls pituitary anterior lobe cell proliferation.
Mol Cell Biol
; 34(12): 2121-34, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24687853
16.
BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development.
Cancer Res
; 74(21): 6161-72, 2014 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25239453
17.
Inflammation, organomegaly, and muscle wasting despite hyperphagia in a mouse model of burn cachexia.
J Cachexia Sarcopenia Muscle
; 3(3): 199-211, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22476919